The Modern Management of Gout: A Fresh Look at an Age-old Disease


C. difficile infection (CDI) remains a significant, and complex, clinical challenge. The number of infections is increasing, and the emergence of a highly virulent strain has further complicated management. Therapeutic options for CDI have changed with the introduction of the first new compound since the 1990s. Clinicians and other healthcare providers must therefore now consider how to include fidaxomicin in treatment strategies. This activity will review best practice to address risk and recurrence and the need to refine management strategies.

Target Audience

This activity has been developed for gastroenterologists who are involved in the management of patients with C. difficile infections. Other healthcare professionals with an interest in C. difficile infections may also attend this activity.